154288-08-1 Usage
Uses
Used in Pharmaceutical Industry:
4-Chloroquinazolin-8-ol is used as a pharmaceutical intermediate for the development of biologically active compounds. Its potential antitumor properties make it a promising candidate for the treatment of various types of cancer. Additionally, its ability to inhibit certain enzymes involved in the biosynthesis of important molecules in organisms contributes to its potential use in the development of new drugs.
Used in Agrochemical Industry:
4-Chloroquinazolin-8-ol is used as an agrochemical intermediate for the synthesis of various compounds with potential applications in agriculture. Its ability to inhibit certain enzymes involved in the biosynthesis of important molecules in organisms can be utilized in the development of new agrochemicals for pest control and crop protection.
Used in Organic Synthesis:
4-Chloroquinazolin-8-ol is used as a key building block in the synthesis of various heterocyclic compounds. Its versatility and value in organic synthesis make it an important intermediate for the development of new compounds with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 154288-08-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,2,8 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 154288-08:
(8*1)+(7*5)+(6*4)+(5*2)+(4*8)+(3*8)+(2*0)+(1*8)=141
141 % 10 = 1
So 154288-08-1 is a valid CAS Registry Number.
154288-08-1Relevant academic research and scientific papers
QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS
-
Page/Page column 80, (2021/06/22)
The present invention relates to a compounds of general formula (I) inhibiting lysophosphatidic acid receptor 2 (LPA2), particularly the invention relates to compounds that are quinazoline derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of LPA receptors, in particular fibrosis.
